KYTX Institutional Ownership & Shareholders
KYVERNA THERAPEUTICS INC (KYTX) is currently held by 124 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $332.78M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Gordonmd Global Investments Lp is currently the largest disclosed institutional shareholder of KYTX tracked by InsiderSet, reporting ownership valued at approximately $37.82M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $22.16M, representing an estimated loss of -41.41% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 65% of the total disclosed KYTX value among the investors covered in this analysis. Major shareholders include Gordonmd Global Investments Lp, Gilead Sciences, Inc., Blackrock, Inc., and several other long-term asset managers with concentrated positions in KYVERNA THERAPEUTICS INC (KYTX).
This page ranks the largest institutional KYTX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
124
Total Reported Value
$332.78M
Largest Holder
Gordonmd Global Investments Lp
Largest Position
$37.82M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
158
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Gordonmd Global Investments Lp | 18.30% | 4,244,818 | $37,821,328 | $22,157,950 | -$15,663,378 | -41.41% | |
| Gilead Sciences, Inc. | 2.23% | 4,126,119 | $36,763,720 | $21,538,341 | -$15,225,379 | -41.41% | |
| Blackrock, Inc. | 0.00% | 3,134,807 | $27,931,130 | $16,363,693 | -$11,567,437 | -41.41% | |
| Bain Capital Life Sciences Investors, Llc | 1.53% | 2,885,000 | $25,705,350 | $15,059,700 | -$10,645,650 | -41.41% | |
| Aigh Capital Management Llc | 2.82% | 3,650,000 | $24,820,000 | $19,053,000 | -$5,767,000 | -23.24% | |
| Deerfield Management Company, L.P. | 0.19% | 2,000,000 | $17,820,000 | $10,440,000 | -$7,380,000 | -41.41% | |
| Vanguard Capital Management Llc | 0.00% | 1,897,451 | $16,906,288 | $9,904,694 | -$7,001,594 | -41.41% | |
| Price T Rowe Associates Inc | 0.00% | 1,186,023 | $10,569,000 | $6,191,040 | -$4,377,960 | -41.42% | |
| Geode Capital Management, Llc | 0.00% | 1,049,430 | $9,352,537 | $5,478,025 | -$3,874,512 | -41.43% | |
| Insight Holdings Group, Llc | 0.67% | 989,054 | $8,812,471 | $5,162,862 | -$3,649,609 | -41.41% | |
| Morgan Stanley | 0.00% | 982,307 | $8,752,355 | $5,127,643 | -$3,624,712 | -41.41% | |
| State Street Corp | 0.00% | 982,233 | $8,751,696 | $5,127,256 | -$3,624,440 | -41.41% | |
| Propel Bio Management, Llc | 4.12% | 883,198 | $7,869,294 | $4,610,294 | -$3,259,000 | -41.41% | |
| Woodline Partners Lp | 0.02% | 845,325 | $7,531,846 | $4,412,597 | -$3,119,250 | -41.41% | |
| Millennium Management Llc | 0.00% | 639,780 | $5,700,440 | $3,339,652 | -$2,360,788 | -41.41% | |
| Mbb Public Markets I Llc | 0.59% | 614,477 | $5,474,990 | $3,207,570 | -$2,267,420 | -41.41% | |
| Adage Capital Partners Gp, L.L.C. | 0.01% | 500,000 | $4,455,000 | $2,610,000 | -$1,845,000 | -41.41% | |
| D. E. Shaw & Co., Inc. | 0.00% | 469,346 | $4,181,872 | $2,449,986 | -$1,731,886 | -41.41% | |
| Wells Fargo & Company/Mn | 0.00% | 373,009 | $3,323,510 | $1,947,107 | -$1,376,403 | -41.41% | |
| Ubs Group Ag | 0.00% | 365,574 | $3,257,264 | $1,908,296 | -$1,348,968 | -41.41% | |
| Goldman Sachs Group Inc | 0.00% | 335,230 | $2,986,899 | $1,749,901 | -$1,236,998 | -41.41% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 333,899 | $2,975,040 | $1,742,953 | -$1,232,087 | -41.41% |
| Charles Schwab Investment Management Inc | 0.00% | 319,666 | $2,848,224 | $1,668,657 | -$1,179,567 | -41.41% | |
| Northern Trust Corp | 0.00% | 315,354 | $2,809,805 | $1,646,148 | -$1,163,657 | -41.41% | |
| Bnp Paribas Financial Markets | 0.00% | 310,632 | $2,767,731 | $1,621,499 | -$1,146,232 | -41.41% | |
| Vanguard Portfolio Management Llc | 0.00% | 282,189 | $2,514,304 | $1,473,027 | -$1,041,277 | -41.41% | |
| Bank Of America Corp | 0.00% | 265,405 | $2,364,759 | $1,385,414 | -$979,345 | -41.41% | |
| Vanguard Fiduciary Trust Co | 0.00% | 259,667 | $2,313,633 | $1,355,462 | -$958,171 | -41.41% | |
| Walleye Capital Llc | 0.01% | 245,587 | $2,188,180 | $1,281,964 | -$906,216 | -41.41% | |
| Nuveen, Llc | 0.00% | 233,743 | $2,082,650 | $1,220,138 | -$862,512 | -41.41% | |
| Burkehill Global Management, Lp | 0.06% | 200,000 | $1,782,000 | $1,044,000 | -$738,000 | -41.41% | |
| Susquehanna International Group, Llp | 0.00% | 155,800 | $1,388,178 | $813,276 | -$574,902 | -41.41% | |
| Bridgeway Capital Management, Llc | 0.02% | 149,900 | $1,335,609 | $782,478 | -$553,131 | -41.41% | |
| Citadel Advisors Llc | 0.00% | 147,627 | $1,315,357 | $770,613 | -$544,744 | -41.41% | |
| Td Asset Management Inc | 0.00% | 145,682 | $1,298,027 | $760,460 | -$537,567 | -41.41% | |
| Stifel Financial Corp | 0.00% | 139,965 | $1,247,088 | $730,617 | -$516,471 | -41.41% | |
| Simplify Asset Management Inc. | 0.02% | 182,603 | $1,241,700 | $953,188 | -$288,512 | -23.24% | |
| Qube Research & Technologies Ltd | 0.00% | 123,646 | $1,101,686 | $645,432 | -$456,254 | -41.41% | |
| Barclays Plc | 0.00% | 117,844 | $1,049,991 | $615,146 | -$434,845 | -41.41% | |
| Wellington Management Group Llp | 0.00% | 117,442 | $1,046,409 | $613,047 | -$433,362 | -41.41% | |
| Wesbanco Bank Inc | 0.02% | 110,300 | $982,773 | $575,766 | -$407,007 | -41.41% | |
| Jump Financial, Llc | 0.01% | 101,352 | $903,046 | $529,057 | -$373,989 | -41.41% | |
| Bank Of New York Mellon Corp | 0.00% | 100,281 | $893,504 | $523,467 | -$370,037 | -41.41% | |
| Fmr Llc | 0.00% | 96,051 | $855,813 | $501,386 | -$354,427 | -41.41% | |
| Balyasny Asset Management L.P. | 0.00% | 96,048 | $855,788 | $501,371 | -$354,417 | -41.41% | |
| Susquehanna Portfolio Strategies, Llc | 0.01% | 88,845 | $791,609 | $463,771 | -$327,838 | -41.41% | |
| Squarepoint Ops Llc | 0.00% | 82,867 | $738,345 | $432,566 | -$305,779 | -41.41% | |
| Manufacturers Life Insurance Company, The | 0.00% | 82,207 | $732,464 | $429,121 | -$303,343 | -41.41% | |
| Dimensional Fund Advisors Lp | 0.00% | 78,419 | $698,713 | $409,347 | -$289,366 | -41.41% | |
| Nano Cap New Millennium Growth Fund L P | 0.48% | 70,000 | $623,700 | $365,400 | -$258,300 | -41.41% |
Frequently asked questions about KYTX
Who are the largest institutional holders of KYTX?
The largest institutional holders of KYTX reported in the latest SEC Form 13F filings include Gordonmd Global Investments Lp, Gilead Sciences, Inc., Blackrock, Inc., Bain Capital Life Sciences Investors, Llc, and Aigh Capital Management Llc. InsiderSet ranks institutional holders by their latest reported KYTX position.
What is KYTX institutional ownership?
This page tracks KYTX positions reported by institutional investment managers through SEC Form 13F. KYVERNA THERAPEUTICS INC (KYTX) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own KYTX?
InsiderSet currently tracks 124 institutional managers reporting KYTX holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of KYTX shareholders.
How much KYTX stock do institutions own?
Institutional investment managers disclosed approximately $332.78M in KYTX holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was KYTX institutional ownership last updated?
The latest KYTX institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional KYTX holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its KYTX position after the reporting date.
Are institutions buying or selling KYTX?
Institutional buying and selling can be analyzed by comparing KYTX positions across consecutive 13F reporting periods. InsiderSet's KYTX Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View KYTX ownership changes.
How has KYTX institutional ownership changed over time?
InsiderSet tracks KYTX institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.